Perfis

Paul Watkins

Professor of Pharmacy, Medicine and Public Health University of North Carolina, Chapel Hill

E-mail confirmado em med.unc.edu

Citado por 45541

Drug-Induced Liver Injury

Guruprasad Aithal

University of Nottingham and NIHR Nottingham Biomedical Research Centre

E-mail confirmado em nottingham.ac.uk

Citado por 38107

Drug-induced Liver Injury Non-alcoholic fatty liver disease Hepatopancreaticobiliary imaging

Raymond Evers

Johnson & Johnson Innovative Medicine

E-mail confirmado em its.jnj.com

Citado por 17366

Drug transporters Drug-Drug Interactions Enzyme Induction Drug-Induced Liver Injury ADME

MI Lucena

University of Málaga, spain

E-mail confirmado em uma.es

Citado por 16740

Drug-Induced Liver injury

Pieter Annaert

Full professor KU Leuven

E-mail confirmado em kuleuven.be

Citado por 14623

pharmacology pharmacokinetics drug induced liver injury pharmacometrics

Robyn Kiy

PhD researcher, University of Liverpool

E-mail confirmado em liverpool.ac.uk

Citado por 8677

Drug-induced liver injury mitochondrial genetics

Vincent Lo Re III, MD, MSCE

Associate Professor of Medicine & Epidemiology, University of Pennsylvania

E-mail confirmado em pennmedicine.upenn.edu

Citado por 8667

Viral hepatitis HIV/viral hepatitis coinfection pharmacoepidemiology drug-induced liver injury

Reza Heidari

Pharm.D. & Toxicology PhD, Shiraz University of Medical Sciences

E-mail confirmado em sums.ac.ir

Citado por 7028

Mechanistic Toxicology Drug-Induced Liver Injury Mitochondria Oxidative Stress Tissue Fibrosis

Minjun Chen

the US FDA's National Center for Toxicological Research

E-mail confirmado em fda.hhs.gov

Citado por 6809

bioinformatics drug-induced liver injury drug safety personalized medicine

Mark Avigan

Associate Office Director, FDA & Professor (Adjunct), Georgetown U. School of Medicine

E-mail confirmado em fda.hhs.gov

Citado por 6544

Liver Disease Molecular Science Therapeutic targets Drug-induced liver injury

1 - 10